Tilray Brands (TLRY) Current Assets (2017 - 2026)
Tilray Brands (TLRY) reported Current Assets of $718.8 million for Q1 2026, up 967.11% on a YoY basis from $67.4 million in Q1 2025, and down 1.45% quarter-over-quarter from $729.3 million in Q4 2025.
Tilray Brands (TLRY) Current Assets (2017 - 2026) Analysis & Trends
Tilray Brands has reported Current Assets for 10 years, with the latest figure at $718.8 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 967.11% year-over-year to $718.8 million; the trailing twelve-month figure through Feb 2026 stood at $718.8 million (up 967.11% YoY), and the FY2025 full-year result was $688.6 million, up 1.61% from the prior year.
- Current Assets for Q1 2026 stood at $718.8 million, down from $729.3 million in the prior quarter.
- The five-year high for Current Assets was $910.9 million in Q3 2022, with the low at $67.4 million in Q1 2025.
- Historically, Current Assets has averaged $698.5 million across 5 years, with a median of $718.8 million in 2026.
- Annual changes were most pronounced in 2025 — Current Assets tumbled 89.33% — and 2026, when it soared 967.11%.
- Tilray Brands' Current Assets stood at $814.7 million in 2022, then retreated by 21.2% to $642.0 million in 2023, then advanced by 10.17% to $707.3 million in 2024, then grew by 3.11% to $729.3 million in 2025, then decreased by 1.45% to $718.8 million in 2026.
- The last three Current Assets figures came in at $718.8 million (Q1 2026), $729.3 million (Q4 2025), and $701.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.71 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 6.47 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 2.87 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.44 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.58 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.36 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 942.29 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.05 Bn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 718.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 718.76 Mn |
| Nov 30, 2025 | 729.32 Mn |
| Aug 31, 2025 | 701.14 Mn |
| May 31, 2025 | 688.63 Mn |
| Feb 28, 2025 | 67.36 Mn |
| Nov 30, 2024 | 707.34 Mn |
| Aug 31, 2024 | 725.88 Mn |
| May 31, 2024 | 677.71 Mn |
| Feb 29, 2024 | 631.21 Mn |
| Nov 30, 2023 | 642.03 Mn |
| Aug 31, 2023 | 829.26 Mn |
| May 31, 2023 | 773.03 Mn |
| Feb 28, 2023 | 758.51 Mn |
| Nov 30, 2022 | 814.71 Mn |
| Aug 31, 2022 | 910.88 Mn |
| May 31, 2022 | 803.50 Mn |
| Feb 28, 2022 | 695.79 Mn |
| Nov 30, 2021 | 708.28 Mn |
| Aug 31, 2021 | 844.62 Mn |
| May 31, 2021 | 883.61 Mn |